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Abstract:  Apoptosis,  also  called  programmed  cell  death,  is  an  orderly  cellular  suicide 
program  that  is  critical  for  the  development,  immune  regulation  and  homeostasis  of  a 
multi-cellular organism. Failure to control this process can lead to serious human diseases, 
including  many  types  of  cancer,  neurodegenerative  diseases,  and  autoimmununity.  The 
process  of  apoptosis  is  mediated  by  the  sequential  activation  of  caspases,  which  are 
cysteine proteases. Initiator caspases, such as caspase-2, -8, -9, and -10, are activated by 
formation  of  caspase-activating  complexes,  which  function  as  a  platform  to  recruit 
caspases, providing proximity for self-activation. Well-known initiator caspase-activating 
complexes  include  (1)  DISC  (Death  Inducing  Signaling  Complex),  which  activates 
caspases-8 and 10; (2) Apoptosome, which activates caspase-9; and (3) PIDDosome, which 
activates caspase-2. Because of the fundamental biological importance of capases, many 
structural  and  biochemical  studies  to  understand  the  molecular  basis  of  assembly 
mechanism  of  caspase-activating  complexes  have  been  performed.  In  this  review,  we 
summarize previous studies that have examined the structural and biochemical features of 
caspase-activating  complexes.  By  analyzing  the  structural  basis  for  the  assembly 
mechanism  of  the  caspase-activating  complex,  we  hope  to  provide  a  comprehensive 
understanding of caspase activation by these important oligomeric complexes. 




Apoptosis, also called programmed cell death, is an orderly cellular suicide program that plays 
critical roles in embryonic development, immune regulation and cellular homeostasis [1–5]. Failure to 
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control the apoptosis process, due to genetic mutations or abnormal expression of apoptosis-related 
proteins, can cause serious human diseases [2,6]. For example, hypo-activation of apoptosis is often 
associated with cancer, autoimmune disorders, and persistent viral infection, while hyper-activation of 
apoptosis is linked to many forms of neurodegenerative disorders such as Alzheimer’s disease and 
ischemic injury from stroke [7–12].  
The process of apoptosis involves the sequential activation of particular proteases called caspases. 
For  activation  during  the  apoptotic  process,  caspases  must  form  huge  molecular  complexes  for  
self-activatation [13–18]. Two classical signaling pathways of apoptosis are well known: the extrinsic 
pathway and the intrinsic pathway [19]. The extrinsic pathway, which is also called the death-receptor 
dependent pathway, functions to remove unwanted or potentially dangerous cells. Death receptors are 
localized  on  cell  surfaces  and  are  activated  by  soluble  or  membrane  attached  death  ligands  [20]. 
Activated  ligand-bound  receptors  form  oligomeric  caspase-activating  complexes,  called  death-
inducing signaling complex (DISC), which are formed by the receptor Fas, the intracellular adaptor 
FADD and caspase-8 or -10 [21,22]. In contrast, the intrinsic pathway, which is also known as the 
mitochodria-dependent pathway, is triggered by cellular damages or stress. It causes cytochrome c 
release from the mitochondria, which results in the formation of the caspase-9 activating complex 
apoptosome [23–25]. More recently, caspase-2 was shown to be involved in the intrinsic apoptosis 
pathway by acting upstream of the mitochondria [26]. Genotoxic stress is known as a trigger for the 
activation of capsase-2 [27]. Caspase-2 is activated by forming the caspase-activating complex, known 
as PIDDosome, which comprises PIDD, RAIDD and caspase-2 [27–29]. 
In  this  review,  we  summarized  previous  studies  that  examined  the  structural  and  biochemical 
features  of  caspase-activating  complexes,  including  apoptosome,  DISC,  and  PIDDosome.  By 
analyzing the structural basis for the assembly mechanism of the caspase-activating complex, we hope 
to provide a comprehensive understanding of caspase activation by these important oligomeric complexes. 
2. Caspase 
Apoptosis proceeds through characteristic morphological changes that are dependent on caspase activity. 
Caspases are cysteine proteases that specifically cleave proteins after aspartic acid residues [13,30]. 
They  are  synthesized  as  single-chain  zymogens  and  require  a  highly  regulated  process  for  their 
activation  (Figure  1A).  Fully  activated  caspases  are  dimeric  with  two  large  subunits  and  two  
small subunits in general (Figure 1B). Both cleavage and dimerization are important to the integrity of 
the  caspase  active  sites  and  therefore  are  required  for  caspase  activation  [31].  Cleavage  and 
dimerization-dependent  caspase  activation  is  still  a  question  under  debate  because  several  study 
showed that cleavage and dimerization of caspase-9 were not required for its activation [32,33]. 
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Figure 1. Initiator caspases and their activation. (a) Domain boundary of initiator caspase. 
Red arrows indicate proteolytic sites. Red circle indicates the catalytic sites; (b) Activated 
caspases.  Red  circles  indicates  the  catalytic  sites;  (c)  Domain  boundary  of  initiator 
caspases and caspase-activating complex.  
 
Because caspases are the executioners of apoptosis, they are the key players in apoptotic cell death [34]. 
Caspases have been divided into two groups based on their sequence of activation and their roles in 
apoptosis; initiator caspases, such as caspase-2, 8, 9 and 10, and effector caspases, such as caspase-3 
and 7. Initiator caspases, which have N-terminal prodomains for protein-protein interaction, are mostly 
monomeric  in  their  pre-forms  (Figure  1C).  They  are  activated  and  auto-processed  upon  induced 
dimerization by recruitment to huge oligomeric signaling complexes known as DISC for caspase-8, 10 
activation,  Apoptososme  for  caspase-9  activation,  and  PIDDosome  for  caspase-2  activation  [35] 
(Figure 1C).  
3. Caspase-Activating Complexes and Death Domain Superfamily 
The DD superfamily is one of the largest and most studied domain superfamilies [17,36]. It is 
currently comprised of four subfamilies, the death domain (DD) subfamily, the death effector domain 
(DED) subfamily, the caspase recruitment domain (CARD) subfamily and the pyrin domain (PYD) 
subfamily [36]. Based on a genome analysis, 32 DDs, 7 DEDs, 28 CARDs and 19 PYDs have been 
identified in the human genome [36]. The unifying feature of the DD superfamily is the six-helical Int. J. Mol. Sci. 2012, 13  4810 
 
 
bundle structural fold as first revealed by NMR structures of Fas DD [37], FADD DED [38], RAIDD 
CARD [39] and NALP1 PYD [40]. One of the main functions of the DD superfamily in apoptotic and 
inflammatory  signaling  pathways  is  the  formation  of  oligomeric  signaling  complexes  through 
homotypic interactions [18,19]. Caspase-8, 10 DED and Fas DD interact with FADD DED and FADD 
DD  respectively for  DISC assembly [41]. For the assembly  of the  apoptosome, caspase-9 CARD 
interacts with Apaf-1 CARD [42]. In the case of PIDDosome assembly, caspase-2 CARD and PIDD 
DD interact with RAIDD CARD and RAIDD DD, respectively [27]. 
4. DISC 
To remove healthy but unwanted or potentially dangerous cells, cell surface death receptors, which 
are members of the tumor necrosis factor (TNF) receptor superfamily, recognize death ligands in the 
beginning of the process. The interaction between death receptors and death ligands  cause highly 
specific protein-protein associations to generate the oligomeric caspase-activating complex inside the 
cell, such as DISC. Death receptors, including Fas, contain a death domain (DD) in their intracellular 
regions, which is an adaptor module capable of homotypic interactions [43]. Upon ligand activation, 
the DD of Fas recruits the FADD adaptor protein via a homotypic interaction with the C-terminal DD 
of FADD (Figure 2A). FADD also contains an N-terminal DED that interacts with the tandem DED in 
the pro-domain of caspase-8 or -10 (Figure 2A). These interactions form the ternary DISC containing 
Fas, FADD and caspase-8 or -10 (Figure 2A). The recruitment and oligomerization of caspase-8 and  
-10 in the DISC result in its autocatalytic activation.  
Two fundamentally different interaction modes between Fas and FADD have been detected recently. 
Based on the Fas DD:FADD DD complex structure,which was solved under acidic pH conditions, 
demonstrated  the  formation  of  DISC  can  only  be  regulated  by  Fas  receptor  clustering  [44].  The 
structure was constructed with four Fas DD and four FADD DD (Figure 2B). Interestingly, in the 
formation  of  the  complex,  all  of  the  contacts  were  mediated  by  Fas  DD  (Figure  2B).  The  key 
observation was that Fas DD underwent significant conformational changes when compared to the 
structure of the uncomplexed Fas DD. The structure determined in more recent studies were not in 
agreement  with  the  Fas  DD:FADD  DD  complex  structure  [45].  Unlike  the  previously  elucidated 
structure, the new Fas DD:FADD DD complex was shown to form an asymmetric oligomeric structure 
composed of 5–7 Fas DD and 5 FADD DD, which suggests that the Fas/FADD structure solved under 
acidic  conditions  does  not  represent  the  physiological  structure  in  solution  (Figure  2C).  The 
composition of DDs was similar to that of RAIDD DD:PIDD DD. Thus, the discrepancy between the 
current two Fas DD:FADD DD complex structures, where one was solved at neutal pH conditions and 
the other under acidic pH conditions, was likely due to the differences in the pH condition.  
A more recent structural and biochemical study on DISC indicated that the dimer of the death 
ligand  trimers  may  recruit  six  Fas  DD  and  accommodate  six  FADD  and  six  caspases  for  DISC 
assembly and caspase activation. However, the mysterious stoichiometry of the DISC-related proteins 
between the outside (trimeric death ligand and receptor interaction) and inside of the cell (4:4 or 5:5 
assembly of Fas DD: FADD DD) and the structural discrepancy at different pH needs to be examined 
in more detail to better understand DISC assembly (Figure 2D). 
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Figure  2.  (a)  Domain  organization  of  the  Death  Inducing  Signaling  Complex  (DISC) 
components, Fas, FADD, and caspase-8 or 10; (b) Overview of the Fas DD: FADD death 
domain (DD) complex structure solved under acidic pH conditions (Top view) (PDB id: 
3EZQ). Four Fas DDs (orange color) are located inside of the complex structure and four 
FADD DDs (light pink color) are located outside of the complex structure; (c) Overview of 
the Fas DD: FADD DD complex structure solved under neutral pH conditions (Top view) 
(PDB id: 3OQ9). The top layer contains five Fas DD (orange color) and bottom layer 
contains five FADD DD (light pink color); (d) A model of the DISC for caspase-8 or 10 
activation. The question mark was used to show the uncertainty in the stoichiometry and 
overall shape of DISC. 
 
5. Apoptosome 
The mitochondria are the central players in the intrinsic apoptotsis pathway and caspase-9 is major 
initiator caspase in this process. Leakage of resident proteins from the mitochondrial intermembrane 
space to the cytosol, which can occur for many reasons, such as irreversible DNA damage, survival 
factor  withdrawal, hypoxia, and UV irradiation, is  the one of the main initial  events  for intrinsic 
apoptosis. One of the most important mitochondrial proteins that get released during intrinsic apoptosis 
is cytochrome C, which is a bifunctional protein that functions in electron transport and apoptosis. The 
release of cytochrome C to the cytosol helps to assemble the Apoptosome, which contains Apaf-1, 
caspase-9, and cytochrome C [46] (Figure 3A). Apaf-1, the central component of the apoptosome, 
contains  an  N-terminal  CARD,  an  expanded  nucleotide-binding  domain  and  a  C-terminal  WD40 Int. J. Mol. Sci. 2012, 13  4812 
 
 
domain (Figure 3A). Apaf-1 CARD is  responsible for the interaction with the caspasae-9 CARD, 
which is essential to the recruitment and the activation of caspase-9 (Figure 3B). A structural study on 
the Apaf-1 CARD: caspase-9 CARD complex revealed that they form a hetero-dimeric interaction, 
which is unlike DD complex in DISC complex (Figure 3B) [47]. The most recent study, however, 
showed the possibility for the formation of super-helical complex between Apaf-1 CARD and caspase-9 
CARD  [33].  The  nucleotide-binding  domain  of  Apaf-1  has  been  shown  to  be  responsible  for 
oligomerization in the presence of cytochrome C and dATP. In the absence of signal, Apaf-1 exists as 
a  monomer.  However,  during  the  apoptotic  process,  after  the  release  of  cytochrome  C  from 
mitochondria, Apaf-1 oligomerizes to form a heptameric ring-shaped molecular platform, called an 
Apoptosome, which contains seven Apaf-1, each bound to one molecule of cytochrome C (Figure 3C 
and 3D) [24,48]. Recent structural studies showed that the assembly of apoptosome itself (without 
caspase-9) does not require Apaf-1 CARD: caspase-9 CARD interaction, nor does it require Apaf-1 
CARD:  Apaf-1  CARD  interaction  (Figure  3D)  [33,49,50].  The  stoichiometry  of  caspase-9  in 
apoptosome is unclear. The caspase-9 to Apaf-1 ratio could be from 5:7 to 7:7 [33].  
Figure 3. (a) Domain organization of the Apoptosome components, Apaf-1, Cyt. C, and 
caspase-9; (b) Overview of the caspase-9 caspase recruitment domain (CARD): Apaf-1 
CARD  complex  structure  (PDB  id:3YGS).  (c)  Electron-microscopy  structure  of 
Apoptosome at a 12 Å resolution without caspase-9. The apoptosome adopts a wheel-like 
structure; (d) A model of the Apoptosome for caspase-9 activation. Schematic of caspase-9 
dimerization to show proximity-induced dimerization in the Apoptosome.  
 




Caspase-2 is an initiator caspase and the most evolutionarily conserved caspase [26]. Caspase-2 acts 
upstream of the mitochondria and is involved in Bid cleavage and Bax translocation, which results in 
cytochrome c release during genotoxic stress [51]. The caspase-2 activating complex, PIDDosome, is 
composed of three protein components, PIDD, RAIDD and caspase-2 (Figure 4A). It is assembled via 
a DD: DD interaction between RAIDD and PIDD and a CARD: CARD interaction between RAIDD 
and caspase-2 (Figure 4A). PIDD DD is not only essential for the activation of caspase-2, but can also 
interact with the DD of RIP1, a kinase implicated in the activation of NF-κB [52]. PIDD appears to act 
as a molecular switch, controlling the balance between life and death upon DNA damage. Full length 
PIDD  contains  910  residues  with  seven  leucine  rich  repeats  (LRRs),  two  ZU-5  domains  and  a  
C-terminal  DD.  It  is  often  auto-processed  via  an  intein-like  mechanism  into  shorter  fragments  of  
51 kD, 48 kD and 37 kD [53]. Auto-cleavage of PIDD determines the outcome of the downstream 
signaling events. PIDD-CC containing the C-terminal DD is sufficient for PIDDosome formation and 
caspase-2 activation [54].  
Figure  4.  (a)  Domain  organization  of  the  PIDD,  RAIDD,  caspase-2,  which  is  the 
PIDDosome component; (b) Overview of the RAIDD DD: PIDD DD complex structure 
(Top view). The top layer contains two RAIDD DD (green color), the middle layer contains 
five RAIDD DD (orange color), and bottom layer contains five PIDD DD (light blue color) 
(PDB id: 2OF5); (c) A model of the PIDDosome for caspase-2 activation. Caspase-2 are 
schematically dimerized to show proximity-induced dimerization in the PIDDosome. 
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The crystal structure of the PIDDosome core, which is composed of seven RAIDD DDs and five 
PIDD DDs, has been determined [18] (Figure 4B). The DD complex is divided into three layers; five 
PIDD DDs at the bottom, five RAIDD DDs in the middle, and two additional RAIDD DDs at the top 
(Figure 4A). Interestingly, this DD complex does not possess a distinct fivefold symmetry. Instead, the 
complex  consists  of  two  different  types  of  unique  rotation  angles,  one  rotating  around  84°   and 
translating down the axis and the other rotating around 54°  and translating up the axis. The complex is 
formed by three different types of interactions that are classified based on the regions involved in  
the interaction.  
Based on the current structural and biochemical information on PIDDosome, it might be possible 
that five or seven RAIDD interact with five PIDD DD and five or seven caspase-2, forming the round 
shape  caspase-2  docking  station  (Figure  4C).  The  molecular  structure  of  the  ternary  complex, 
containing RAIDD, PIDD, caspase-2, should be solved to provide clear evidence of the stoichiometry, 
shape of the PIDDosome, and activation mechanism of initiator caspases. 
7. Conclusions  
The apoptosis process is mediated by sequential activation of caspases. To understand apoptotic cell 
death,  therefore,  many  studies  have  examined  the  caspase  activation  mechanism.  Despite  intense 
structural and biochemical investigations, there are still many unknown features of the caspase and 
caspase  activation  mechanism.  This  review  summarizes  the  most  recent  structural  studies  on  the  
caspase-activating  complexes.  The  key  common  event  for  activating  initiator  caspases  is 
oligomerization, which allows the formation of activating dimmers. The recruitment of caspase by 
those caspase-activating complexes results in a local increase in the concentration of caspase, which 
subsequently become activated by proximity-induced dimerization.  
The assembly mechanism of DISC, Apoptosome, and PIDDosome has been examined in several 
prevoius structural studies. For DISC assembly, it is possible that a dimer of the death ligand trimers 
binds to six Fas DD and accommodates six FADD and six caspases, resulting in caspase activation. 
However, because of the structural changes in the DISC under different pH conditions, the process of 
DISC  formation  is  still  unclear.  The  apoptosome,  which  is  a  heptameric  ring-shaped  molecular 
platform, contains seven Apaf-1, each bound to one molecule of cytochrome C and one caspase-9. 
PIDDosome  is  composed  of  five  or  seven  RAIDD,  five  PIDD  DD,  and  five  or  seven  caspase-2. 
However, the structure of the ternary complex, containing RAIDD, PIDD, caspase-2, still needs to  
be determined.  
Beside  apoptotic  caspases,  there  are  caspases  involved  in  inflammation,  which  are  called 
inflammatory  caspases,  including  caspase-1  and  -5.  Similar  to  the  activation  process  of  apoptotic 
caspases,  activation  of  inflammatory  caspases  occurs  throught  the  formation  of  huge  
caspase-activating complexes, called inflammasomes. One of the most well studied inflammasome is 
the  NALP3  inflammasome,  which  is  composed  of  three  components,  NALP3,  ASC,  and  
caspase-1 [55]. NALP3 is expected to function as intracellular danger signal sensor and consists of an 
N-terminal PYD domain, an intermediate NATCH domain, and C-terminal leucine-rich repeats. ASC 
is a bipartite adaptor protein that consists of an N-terminal PYD domain and a C-terminal CARD 
domain. Caspase-1 contains a CARD domain at the N-terminus. Although it has been known that Int. J. Mol. Sci. 2012, 13  4815 
 
 
NALP3 inflammasome is assembled via a PYD:PYD interaction between ASC and NALP3 and a 
CARD:CARD interaction between ASC and caspase-1, no structural information of the inflammasome 
complex is available. It might be very interesting to determine if the structure of the inflammasome is 
similar to those of DISC, Apoptosome, and PIDDosome. Recently introduced protein-protein database 
for the death domain superfamily will be helpful to study the death domain superfamily mediated 
formation of caspase-activating complexes [56]. 
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